Having Diagnostics and Pharma in one company is a powerful advantage that sets Roche apart. Two thirds of our medicine R&D projects are being developed with companion diagnostics.
RDS is researching and developing comprehensive end-to-end diagnostics solutions to address the needs of labs and Points of Care.
RIS is researching and developing digital solutions to help deliver medical value on integrated testing solutions, enabling confident healthcare decisions and improving care along the patient journey.
RDC is researching and developing solutions for glucose monitoring and insulin delivery to support people with diabetes and those at risk to reach their therapy goals and spend more time in range.
The Roche Group has a truly global spread of research, diagnostics and pharma development, data analytics and genomic insight teams at locations across 17 countries, spanning four continents, all working to translate science and research into ground-breaking therapies and diagnostics.
We believe in the power of our strong partnership network driving pioneering scientific and technological breakthroughs across healthcare through diversity of cultures and scientific thinking.